Melqart Asset Management (UK) Ltd: CYTOKINETICS INC (CYTK): Quarterly 13F Position History
As of Q1 2026, Melqart Asset Management (UK) Ltd reported 843,949 shares of CYTOKINETICS INC (CYTK), worth $55.6M and representing 5.5% of its 13F equity book. Quarter-over-quarter share count change: + 221,051 (+35.5%) . The position first appeared in Q1 2024 and has been disclosed across 9 13F-HR filings in Pactolio's tracked window.
- 843,949Shares Held (Latest Filing)
- $55.6MReported Market Value (Latest Filing)
- 5.5%Portfolio Weight (% of 13F Equity Book)
- +221,051Quarter-over-Quarter Share Change
- +$16.0MQuarter-over-Quarter Value Change
- 1,675,785Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 9 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 843,949 | +221,051 | +35.5% | $55.6M | 5.5% | $65.9 |
| Q4 2025 | 622,898 | 160,876 | -20.5% | $39.6M | 4.0% | $63.5 |
| Q3 2025 | 783,774 | 542,945 | -40.9% | $43.1M | 5.7% | $55.0 |
| Q2 2025 | 1,326,719 | +327,272 | +32.7% | $43.8M | 6.3% | $33.0 |
| Q1 2025 | 999,447 | 136,987 | -12.1% | $40.2M | 5.4% | $40.2 |
| Q4 2024 | 1,136,434 | 75,824 | -6.3% | $53.5M | 7.2% | $47.0 |
| Q3 2024 | 1,212,258 | 463,527 | -27.7% | $64.0M | 6.3% | $52.8 |
| Q2 2024 | 1,675,785 | +692,390 | +70.4% | $90.8M | 8.5% | $54.2 |
| Q1 2024 | 983,395 | — | — | $68.9M | 5.1% | $70.1 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Melqart Asset Management (UK) Ltd first disclose a CYTK position in 13F-HR filings?
Melqart Asset Management (UK) Ltd first reported CYTOKINETICS INC (CYTK) on its 13F-HR filing for the period ending 2024-03-31 (Q1 2024). The position has appeared on 9 reported quarters within Pactolio's tracked window.
What was Melqart Asset Management (UK) Ltd's most recent quarter-over-quarter share-count change in CYTK?
Between Q4 2025 and Q1 2026, Melqart Asset Management (UK) Ltd added 221,051 shares of CYTK (+35.5%), bringing the total reported position to 843,949 shares at a market value of $55.6M.
Does the implied price-per-share represent Melqart Asset Management (UK) Ltd's cost basis in CYTK?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.